BridgeMD
New treatment option for Bonding
Official title The Effect of the Cesarean ERAS Protocol on Mother-Infant and Father-Infant Bonding: a Multicenter, Randomized Controlled Clinical Trial.
ClinicalTrials.gov ID: NCT07276126
What this study is testing
- What it's testing
- This is a multicenter, 1:1 parallel-group, randomized controlled trial designed to compare the effect of the Enhanced Recovery After Cesarean (ERAS) protocol versus standard perioperative care on mother-infant and father-infant bonding in women undergoing cesarean delivery. The study will initially be conducted as a single-center trial at Istanbul Okan University Hospital.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60. Healthy volunteers may be eligible.
You may be able to join if
- Pregnant women aged 18-60 years.
- Singleton, live fetus, and ≥37 weeks of gestation.
- Undergoing elective or medically indicated cesarean delivery.
- Ability to read and understand Turkish (for questionnaire validity).
- Mothers and fathers willing and able to complete postpartum follow-up assessments (2 hours, 24 hours, day 4, day 7).
You likely can't join if
- (Dışlanma Kriterleri)
- Exclusion Criteria:
- Preterm birth (\<37 weeks) or multiple gestation (twins, triplets).
- Stillbirth, early neonatal death, or major congenital anomaly.
- Newborn requiring prolonged NICU stay preventing bonding assessments.
- Maternal severe obstetric complications:
See the full eligibility criteria
- Pregnant women aged 18-60 years.
- Singleton, live fetus, and ≥37 weeks of gestation.
- Undergoing elective or medically indicated cesarean delivery.
- Ability to read and understand Turkish (for questionnaire validity).
- Mothers and fathers willing and able to complete postpartum follow-up assessments (2 hours, 24 hours, day 4, day 7).
- Provision of written informed consent by mother and, if participating, by father/partner.
- Maternal postpartum clinical stability (no condition precluding questionnaire completion).
- (Dışlanma Kriterleri)
- Exclusion Criteria:
- Preterm birth (\<37 weeks) or multiple gestation (twins, triplets).
- Stillbirth, early neonatal death, or major congenital anomaly.
- Newborn requiring prolonged NICU stay preventing bonding assessments.
- Maternal severe obstetric complications:
- Massive postpartum hemorrhage
- Hysterectomy
- Severe preeclampsia or eclampsia
- Severe postpartum infection
- Maternal active psychiatric disorder or use of psychotropic medication.
- Maternal need for high-dose opioid analgesia or sedation interfering with bonding assessments.
- Inability to read/understand Turkish or cognitive impairment preventing questionnaire completion.
- Failure to complete follow-up visits (2 hours, 24 hours, day 4, day 7).
- Withdrawal of consent at any time.
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.